Wolverine Trading’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-23,700
| Closed | -$2.02M | – | 5751 |
|
|
2020
Q3 | $2.02M | Sell |
23,700
-24,400
| -51% | -$1.23M | ﹤0.01% | 1472 |
|
|
2020
Q2 | $1.65M | Buy |
48,100
+15,000
| +45% | +$439K | ﹤0.01% | 1567 |
|
|
2020
Q1 | $455K | Sell |
33,100
-33,400
| -50% | -$562K | ﹤0.01% | 2764 |
|
|
2019
Q4 | $1.42M | Sell |
66,500
-12,100
| -15% | -$213K | ﹤0.01% | 2108 |
|
|
2019
Q3 | $1.13M | Buy |
78,600
+7,500
| +11% | +$110K | ﹤0.01% | 1871 |
|
|
2019
Q2 | $986K | Buy |
71,100
+16,100
| +29% | +$242K | ﹤0.01% | 2048 |
|
|
2019
Q1 | $1.06M | Sell |
55,000
-113,300
| -67% | -$1.83M | ﹤0.01% | 2025 |
|
|
2018
Q4 | $2.52M | Buy |
168,300
+46,900
| +39% | +$931K | 0.01% | 1250 |
|
|
2018
Q3 | $2.53M | Buy |
121,400
+70,600
| +139% | +$1.67M | 0.01% | 1458 |
|
|
2018
Q2 | $742K | Hold |
50,800
| – | – | ﹤0.01% | 2581 |
|
|
2018
Q1 | $742K | Buy |
+50,800
| New | +$830K | ﹤0.01% | 2581 |
|
|
2016
Q4 | – | Sell |
-32,800
| Closed | -$105K | – | 5454 |
|
|
2016
Q3 | $105K | Sell |
32,800
-18,600
| -36% | -$52K | ﹤0.01% | 4167 |
|
|
2016
Q2 | $116K | Buy |
+51,400
| New | +$172K | ﹤0.01% | 3570 |
|
Wolverine Trading's IMMU Position: Q3 2020 in Review
Wolverine Trading sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 18,973 shares — an estimated $959K sold.
Wolverine Trading first reported a position in IMMU in Q2 2016 and held it in 10 quarters. The position peaked at $2.14M in Q3 2018. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.
- Wolverine Trading reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
- Wolverine Trading sold 18,973 Immunomedics Inc shares in Q3 2020, an estimated $959K.
- Wolverine Trading first reported a position in Immunomedics Inc in Q2 2016 and held it in 10 quarters.
- Wolverine Trading's Immunomedics Inc position peaked at $2.14M in Q3 2018.
- 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.
Based on Wolverine Trading's 13F filing for Q3 2020, filed 13 Nov 2020.